Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis

Infection and Immunity

Volumn 78, Issue 2, 2010, Pages 618-628

  Manivannan, B ^a   Rawson, P ^a   Jordan, T W ^a   Secor, W E ^b   La Flamme, A C ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE P1; ISOPROTEIN; LIPOCORTIN 5; LIVER PROTEIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROHIBITIN; PROHIBITIN 2; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIFFERENTIAL IN GEL ELECTROPHORESIS; DISEASE SEVERITY; GEL ELECTROPHORESIS; HEPATOSPLENIC SCHISTOSOMIASIS; HYPERSPLENOMEGALY SYNDROME; LIVER; LIVER DISEASE; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; SCHISTOSOMA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SERUM; SPLENOMEGALY;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER DISEASES; MALE; MICE; MICE, INBRED CBA; PRINCIPAL COMPONENT ANALYSIS; PROTEIN ISOFORMS; PROTEINS; SCHISTOSOMIASIS MANSONI; SPLENIC DISEASES;

EID: 76749110375     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00647-09     Document Type: Article

References (68)

1. Agaton, C., J. Galli, I. H. Guthenberg, L. Janzon, M. Hansson, A. Asplund, E. Brundell, S. Lindberg, I. Ruthberg, K. Wester, D. Wurtz, C. Höög, J. Lundeberg, S. Ståhl, F. Pontén, and M. Uhlén. 2003. Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol. Cell. Proteomics 2:405-414.
2. Altmann, F. 2007. The role of protein glycosylation in allergy. Int. Arch. Allergy Immunol. 142:99-115.
3. Ancelin, M. L., G. Torpier, H. J. Vial, and A. Capron. 1987. Choline incorporation by Schistosoma mansoni: distribution of choline metabolites during development and after sexual differentiation. J. Parasitol. 73:530-535.
4. Arinola, O. G. 2004. Metal binding acute phase proteins and trace elements in Nigerian children with urinary schistosomiasis. Biokemistri 16:23-27.
5. Asahi, H., A. Osman, R. M. Cook, P. T. LoVerde, and M. J. Stadecker. 2000. Schistosoma mansoni phosphoenolpyruvate carboxykinase, a novel egg antigen: immunological properties of the recombinant protein and identification of a T-cell epitope. Infect. Immun. 68:3385-3393.
6. Asamoto, M., and S. M. Cohen. 1994. Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines. Cancer Lett. 83:201-207.
7. Beddek, A. J., P. Rawson, L. Peng, R. Snell, K. Lehnert, H. E. Ward, and T. W. Jordan. 2008. Profiling the metabolic proteome of bovine mammary tissue. Proteomics 8:1502-1515.
8. Blanc, J., C. Lalanne, C. Plomion, J. Schmitter, K. Bathany, J. Gion, P. Bioulac-Sage, C. Balabaud, M. Bonneu, and J. Rosenbaum. 2005. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 5:3778-3789.
9. Boehme, M. W. J., P. K. Kataaha, and E. J. Holborow. 1989. Autoantibodies to intermediate filaments in sera of patients with Schistosoma mansoni infection. Clin. Exp. Immunol. 77:230-233.
10. Brindley, P. J., B. H. Kalinna, J. P. Dalton, S. R. Day, J. Y. M. Wong, M. L. Smythe, and D. P. McManus. 1997. Proteolytic degradation of host hemoglobin by schistosomes. Mol. Biochem. Parasitol. 89:1-9.
11. Capuano, F., F. Guerrieri, and S. Papa. 1997. Oxidative phosphorylation enzymes in normal and neoplastic cell growth. J. Bioenerg. Biomembr. 29:379-384.
12. Chen, H. B., K. Pan, M. K. Tang, Y. L. Chui, L. Chen, Z. J. Su, Z. Y. Shen, E. M. Li, W. Xie, and K. K. H. Lee. 2008. Comparative proteomic analysis reveals differentially expressed proteins regulated by a potential tumor promoter, BRE, in human esophageal carcinoma cells. Biochem. Cell Biol. 86:302-311.
13. Chitsulo, L., D. Engels, A. Montresor, and L. Savioli. 2000. The global status of schistosomiasis and its control. Acta Trop. 77:41-51.
14. Chu, P., J. Pardo, H. Zhao, C. C. Li, E. Pali, M. M. Shen, K. Qu, S. X. Yu, B. C. B. Huang, P. Yu, E. S. Masuda, S. M. Molineaux, F. Kolbinger, G. Aversa, J. De Vries, D. G. Payan, and X. C. Liao. 2003. Systematic identification of regulatory proteins critical for T-cell activation. J. Biol. 2:211-2116.
15. Chu, R., H. Lim, L. Brumfield, H. Liu, C. Herring, P. Ulintz, J. K. Reddy, and M. Davison. 2004. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation. Mol. Cell. Biol. 24:6288-6297.
16. Clemens, L. E., and P. F. Basch. 1989. Schistosoma mansoni: effect of transferrin and growth factors on development of schistosomula in vitro. J. Parasitol. 75:417-421.
17. Dragani, T. A., F. S. Falvella, G. Manenti, M. A. Pierotti, and R. A. Gambetta. 1996. Downexpression of aldehyde dehydrogenase 1 in murine lung tumors. Mol. Carcinog. 16:123-125.
18. Dragani, T. A., G. Manenti, M. R. M. Sacchi, B. M. Colombo, and G. Della Porta. 1989. Major urinary protein as a negative tumor marker in mouse hepatocarcinogenesis. Mol. Carcinog. 2:355-360.
19. Dunn, M. A., R. Kamel, and I. A. Kamel. 1979. Liver collagen synthesis in schistosomiasis mansoni. Gastroenterology 76:978-982.
20. Forestier, M., R. Bänninger, J. Reichen, and M. Solioz. 2003. Betaine homocysteine methyltransferase: gene cloning and expression analysis in rat liver cirrhosis. Biochim. Biophys. Acta 1638:29-34.
21. Giometti, C. S., X. Liang, S. L. Tollaksen, D. B. Wall, D. M. Lubman, V. Subbarao, and M. S. Rao. 2000. Mouse liver selenium-binding protein decreased in abundance by peroxisome proliferators. Electrophoresis 21:2162-2169.
22. Grzych, J. M., E. Pearce, A. Cheever, Z. A. Caulada, P. Caspar, S. Heiny, F. Lewis, and A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistomiasis mansoni. J. Immunol. 146:1322-1327.
23. Guo, W., H. Xu, J. Chen, Y. Yang, J. W. Jin, R. Fu, H. M. Liu, X. L. Zha, Z. G. Zhang, and W. Y. Huang. 2007. Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-β1. Mol. Cell. Biochem. 295:167-177.
24. Hammond, K. D., and D. Balinsky. 1978. Activities of key gluconeogenic enzymes and glycogen synthase in rat and human livers, hepatomas, and hepatoma cell cultures. Cancer Res. 38:1317-1322.
25. Harvie, M., T. W. Jordan, and A. C. La Flamme. 2007. Differential liver protein expression during schistosomiasis. Infect. Immun. 75:736-744.
26. Hayes, P. C., L. May, J. D. Hayes, and D. J. Harrison. 1991. Glutathione S-transferases in human liver cancer. Gut 32:1546-1549.
27. Henderson, G. S., N. A. Nix, M. A. Montesano, D. Gold, G. L. Freeman, Jr., T. L. McCurley, and D. G. Colley. 1993. Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am. J. Pathol. 142:703-714.
28. Henkel, C., M. Roderfeld, R. Weiskirchen, M. L. Berres, S. Hillebrandt, F. Lammert, H. E. Meyer, K. Stühler, J. Graf, and E. Roeb. 2006. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis. Proteomics 6:6538-6548.
29. Hernandez, H. J., Y. Wang, N. Tzellas, and M. J. Stadecker. 1997. Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur. J. Immunol. 27:1170-1176.
30. Israelsson, C., H. Bengtsson, A. Kylberg, K. Kullander, A. Lewén, L. Hillered, and T. Ebendal. 2008. Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J. Neurotrauma 25:959-974.
31. Karp, N. A., and K. S. Lilley. 2005. Maximising sensitivity for detecting changes in protein expression: experimental design using minimal CyDyes. Proteomics 5:3105-3115.
32. Karp, N. A., M. Spencer, H. Lindsay, K. O'Dell, and K. S. Lilley. 2005. Impact of replicate types on proteomic expression analysis. J. Proteome Res. 4:1867-1871.
33. Krupenko, S. A., and N. V. Oleinik. 2002. 10- Formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ. 13:227-236.
34. La Flamme, A. C., E. A. Patton, B. Bauman, and E. J. Pearce. 2001. IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis. J. Immunol. 166:1903-1911.
35. Leal, J. F., I. Ferrer, C. Blanco-Aparicio, J. Hernandez-Losa, C. S. Ramony, A. Carnero, and M. E. Lleonart. 2008. S-Adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis. Carcinogenesis 29:2089-2095.
36. Li, Q., A. K. Ching, B. C. Chan, S. K. Chow, P. Lim, T. C. Ho, W. Ip, C. Wong, C. W. Lam, K. K. Lee, J. Y. Chan, and Y. Chui. 2004. A death receptor-associated anti-apoptotic protein, BRE, inhibits mitochondrial apoptotic pathway. J. Biol. Chem. 279:52106-52116.
37. Lim, S. O., S. Park, W. Kim, S. G. Park, H. Kim, Y. Kim, T. Sohn, J. Noh, and G. Jung. 2002. Proteome analysis of hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 291:1031-1037.
38. Magnussen, P. 2003. Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years' experiences. Acta Trop. 86:243-254.
39. Mehlhorn, H. 2009. Energy metabolism. In H. Mehlhorn (ed.), Parasitology research & encyclopedic reference of parasitology, 2nd ed. Springer-Verlag, Heidelberg, Germany. http://parasitology.informatik.uni- wuerzburg.de.
40. Meier, U., O. Gressner, F. Lammert, and A. M. Gressner. 2006. Gc-globulin: roles in response to injury. Clin. Chem. 52:1247-1253.
41. Mishra, S., L. C. Murphy, B. L. G. Nyomba, and L. J. Murphy. 2005. Prohibitin: a potential target for new therapeutics. Trends Mol. Med. 11: 192-197.
42. Morand, J. F., J. Macri, and K. Adeli. 2005. Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia. J. Biol. Chem. 280:17626-17633.
43. Mulla, A., H. C. Christian, E. Solito, N. Mendoza, J. F. Morris, and J. C. Buckingham. 2004. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin. Endocrinol. 60:107-119.
44. Murray, G. I., P. J. Paterson, R. J. Weaver, S. W. B. Ewen, W. T. Melvin, and M. D. Burke. 1993. The expression of cytochrome P-450, epoxide hydrolase, and glutathione S-transferase in hepatocellular carcinoma. Cancer 71:36-43.
45. Otegbayo, J. A., O. G. Arinola, A. Aje, O. A. Oluwasola, O. H. Okiwelu, and L. S. Salimonu. 2005. Usefulness of acute phase proteins for monitoring development of hepatocellular carcinoma in hepatitis B virus carriers. West Afr. J. Med. 24:124-127.
46. Otogawa, K., T. Ogawa, R. Shiga, K. Ikeda, and N. Kawada. 2009. Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis. Hepatol. Int. 3:378-383.
47. Potter, B. J., R. W. G. Chapman, R. M. Nunes, D. Sorrentino, and S. Sherlock. 1985. Transferrin metabolism in alcoholic liver disease. Hepatology 5:714-721.
48. Rizk, M., T. A. Fayed, M. Badawy, and N. S. El-Regal. 2006. Effect of different durations of Schistosoma mansoni infection on the levels of some antioxidants in mice. Med. J. Islam. World Acad. Sci. 16:25-34.
49. Rudd, P. M., T. Elliott, P. Cresswell, I. A. Wilson, and R. A. Dwek. 2001. Glycosylation and the immune system. Science 291:2370-2376.
50. Reference deleted.
51. Saif, M., J. Tawfik, M. A. Ali, S. F. El-Mahrouky, N. Galil, and M. N. Galal. 1977. Serum transferrin, albumin and IgG levels in hepatosplenic bilharziasis in Egypt. J. Egypt. Med. Assoc. 60:731-743.
52. Salawu, L., and O. G. Arinola. 2004. Acute phase proteins in pregnant women with urinary schistosomiasis in live villages, Osun State, Nigeria. Afr. J. Biomed. Res. 7:103-106.
53. Salmhofer, H., I. Rainer, K. Zatloukal, and H. Denk. 1994. Posttranslational events involved in griseofulvin-induced keratin cytoskeleton alterations. Hepatology 20:731-740.
54. Santos, S. G., E. C. Campbell, S. Lynch, V. Wong, A. N. Antoniou, and S. J. Powis. 2007. Major histocompatibility complex class I-ERp57-tapasin interactions within the peptide-loading complex. J. Biol. Chem. 282:17587-17593.
55. Schiødt, F. V. 2008. Gc-globulin in liver disease. Dan. Med. Bull. 55:131-146.
56. Stadecker, M. J. 1999. The development of granulomas in schistosomiasis: genetic backgrounds, regulatory pathways, and specific egg antigen responses that influence the magnitude of disease. Microbes Infect. 1:505-510.
57. Strathmann, J., K. Paal, C. Ittrich, E. Krause, K. E. Appel, H. P. Glauert, A. Buchmann, and M. Schwarz. 2007. Proteome analysis of chemically induced mouse liver tumors with different genotype. Proteomics 7:3318-3331.
58. Strnad, P., C. Stumptner, K. Zatloukal, and H. Denk. 2008. Intermediate filament cytoskeleton of the liver in health and disease. Histochem. Cell Biol. 129:735-749.
59. Sun, W., B. Xing, Y. Sun, X. Du, M. Lu, C. Hao, Z. Lu, W. Mi, S. Wu, H. Wei, X. Gao, Y. Zhu, Y. Jiang, X. Qian, and F. He. 2007. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis. Mol. Cell. Proteomics 6:1798-1808.
60. Thome-Kromer, B., M. K. I. Bonk, G. Nebrich, M. Taufmann, S. Bryant, U. Wacker, and A. Köpke. 2003. Towards the identification of liver toxicity markers: a proteome study in human cell culture and rats. Proteomics 3:1835-1862.
61. Uchio, K., B. Tuchweber, N. Manabe, G. Gabbiani, J. Rosenbaum, and A. Desmouliere. 2002. Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts. Lab. Invest. 82:619-628.
62. Van der Werf, M. J., S. J. De Vlas, S. Brooker, C. W. N. Looman, N. J. D. Nagelkerke, J. D. F. Habbema, and D. Engels. 2003. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 86:125-139.
63. Van Waes, L., and C. S. Lieber. 1977. Glutamate dehydrogenase: a reliable marker of liver cell necrosis in the alcoholic. Br. Med. J. ii:1508-1510.
64. Vasiliou, V., A. Pappa, and D. R. Petersen. 2000. Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem. Biol. Interact. 129:1-19.
65. Virtanen, T., and T. Kinnunen. 2008. Clinical allergy and immunology series, p. 576. In R. F. Lockey and D. K. Ledford (ed.), Allergens and allergen immunotherapy, 4th ed. Informa Health Care, New York, NY.
66. Wegrzyn, P., J. Jura, T. Kupiec, W. Piekoszewski, B. Wladyka, A. Zarebski, and A. Koj. 2006. A search for genes modulated by interleukin-6 alone or with interleukin-1[beta] in HepG2 cells using differential display analysis. Biochim. Biophys. Acta 1762:319-328.
67. Wynn, T. A., R. W. Thompson, A. W. Cheever, and M. M. Mentink-Kane. 2004. Immunopathogenesis of schistosomiasis. Immunol. Rev. 201:156-167.
68. Yamamoto, S., Y. Tomita, S. Nakamori, Y. Hoshida, H. Nagano, K. Dono, K. Umeshita, M. Sakon, M. Monden, and K. Aozasa. 2003. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J. Clin. Oncol. 21:447-452.